focus
Previous article:
Peter Hotez and the public health issue of online harassment
Next article: Adam's Take: Intra
Next article: Adam's Take: Intra
explore
hotspot
-
Medical devices makers are asking for forgiveness, not permission
2025-09-27 09:36 -
Sanofi to acquire U.S. biotech Inhibrx in $2.2 billion deal
2025-09-27 09:30 -
FDA sets aggressive timeline for overhauling inspection procedures
2025-09-27 08:38 -
U.K. officials, researchers try to ease path for bespoke genetic treatments
2025-09-27 08:21 -
Medicare bonuses could stop drug shortages under Senate plan
2025-09-27 08:02 -
This gene therapy has record $4.25 million price. It's saved children.
2025-09-27 08:01